Oxford Biosignals technology provides intelligent data acquisition and advanced signal interpretation for complex signal monitoring across the Medical and Industrial sectors
home our company techniques what's new info centre partners contact
Oxford BioSignals technology for Patient Health Monitoring Cardiac Safety Aero Engines and Industrial. Our technology enables unique signal interpretation facilitating reduced costs, decision support and condition monitoring. Our specialist expertise includes high volume, real time, data acquisition techniques and system prognosis.

OBS technology generating real business value for Rolls-Royce

Oxford BioSignals, University of Oxford and Rolls-Royce celebrate business value from award winning Engine Health Monitoring technology.

Professor Tarassenko and three Rolls-Royce engineers, Dennis King, Paul Anuzis and Steve King, were presented with the Rolls-Royce High Value Patent Award at the 2008 Sir Henry Royce Awards for Technical Innovation on Tuesday 4th March. The patent entitled "Monitoring the health of a powerplant" was originally taken out in July 2001 and is the basis for the QUICK system, a multi-sensor data acquisition system for real-time jet engine diagnostics. Models of normality automatically identify abnormalities in engine data, providing novelty scores that can be fused together to provide accurate diagnosis. Embedded on Rolls-Royce test beds worldwide, QUICK systems provide invaluable diagnostics during engine troubleshooting. They have reduced diagnosis time and helped eliminate unnecessary maintenance giving savings of £1.4M for the Trent 500 in 2006. Rolls-Royce collaboration continues with Oxford BioSignals and the University of Oxford, on the development of advanced algorithms to maintain Rolls-Royce's world leadership in engine health monitoring technologies.

 

Professor Tarassenko being presented the High Valve Patent award by Mike Terrett, Rolls-Royce's Chief Operating Officer.

 

The QUICK team (centre) with Mike Terrett and Nick Farrant (Chief Executive of Oxford BioSignals) on the left and Colin Smith, Rolls-Royce's Director of Engineering on the far right.

Oxford BioSignals, University of Oxford and Rolls-Royce celebrate business value from award winning Engine Health Monitoring technology read more

In the News ITV and BBC

Industrial Health Monitoring using novelty detection-based neural networks read more

Automated QT Interval Analysis with Confidence Measures read more

Copyright Oxford BioSignals Privacy Notice Legal Notice
Web site by OCTA - design, build and maintain web sites, intranets and corporate presentations